Class A Common Stock Equals or Exceeds $10.00”), (ii) may not, subject to certain limited exceptions as described in the Registration Statement, be transferred, assigned or sold by our sponsor until 30 days after the completion of the Company’s initial business combination (including the Class A Common Stock issuable upon the exercise of such private warrants) and (iii) may be exercised on a cashless basis, in each case so long as they continue to be held by the Sponsor or its permitted transferees. The Sponsor was granted certain demand and piggyback registration rights in connection with the purchase of the Private Units.
The Private Units were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 2, 2021, in connection with the IPO, Mary Elizabeth Higgins, Daniel A. Cassella, Richard Glynn, Jan Jones Blackhurst, Thomas A. Lettero and Daniel H. Scott (collectively with James J. Zenni, Jr., the “Directors”) were appointed to the board of directors of the Company (the “Board”). Effective February 2, 2021, each of Mr. Cassella, Mr. Scott and Mr. Lettero was also appointed to the audit committee of the Board, with Mr. Cassella serving as chair, each of Mr. Scott, Ms. Jones Blackhurst and Mr. Cassella was appointed to the compensation committee of the Board, with Mr. Scott serving as chair, and each of Ms. Jones Blackhurst, Mr. Lettero and Mr. Glynn was appointed to the nominating and corporate governance committee of the Board, with Ms. Jones Blackhurst serving as chair.
Concurrently with the consummation of the IPO, the Company paid a one-time cash bonus of $75,000 and the Sponsor transferred 7,500 shares of the Company’s Class B common stock to each of Mr. Cassella, Mr. Glynn, Ms. Jones Blackhurst, Mr. Lettero and Mr. Scott. The Company will reimburse the Sponsor, the Company’s officers and directors or any of their respective affiliates for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination.
Other than the foregoing, none of the Directors is party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor is any Director party to any transaction required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.
On February 2, 2021, in connection with the IPO, the Company amended and restated its bylaws. On February 2, 2021, in connection with the IPO, the Company filed its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State. The terms of the Amended and Restated Certificate of Incorporation are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Company’s Amended and Restated Bylaws and Amended and Restated Certificate of Incorporation are attached as Exhibits 3.2 and 3.1 hereto, respectively, and are incorporated by reference herein.
Item 8.01 Other Events
As of February 5, 2021, a total of $200,000,000 of the net proceeds from the IPO and the Private Placement were deposited in a trust account established with Continental Stock Transfer & Trust Company, acting as trustee. An audited balance sheet as of February 5, 2021 reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement will be filed within four (4) business days of the consummation of the IPO.
3